Rudra Shares and Stock Brokers LTD.
ABOUT US | CONTACT US| CAREER
BACKOFFICE LOGIN
INDIA INX Global
  ONLINE TRADING
search
Equity

COMPANY NEWS

Aurobindo Pharma LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:524804
ISIN Demat:INE406A01037
Book Value(Rs):318.5455537
NSE Symbol:AUROPHARMA
Div & Yield %:0.65
Market Cap (Rs Cr.):67541.14
P/E(TTM):34.35
EPS(TTM):33.56
Face Value(Rs):1
  Change Company 
Auro Pharma’s Andhra Pradesh facility gets 3 USFDA observations
(08 Apr 2024)

The new injectable facility of Eugia Steriles (a 100% subsidiary of Eugia Pharma Specialities and a stepdown subsidiary of the company), situated at Parawada Mandal, Anakapalli district, Andhra Pradesh, has recently started the commercial operations.

The United States Food and Drug Administration (USFDA) inspected the facility from 28 March 2024 to 5 April 2024.

The inspection closed with three observations. The observations are procedural in nature and will be responded to within the stipulated time, the company stated in the press release.

On 6 April 2024, the company informed that an accident occurred near Vacuum Tray Dryer (VTD) area at Unit 6 of Apitoria Pharma (wholly owned subsidiary of the company), situated at Parawada, Anakapalli district, Andhra Pradesh. The firm said that there was one casualty due to the accident.

Further, the company added the unit continues its normal operations.

Aurobindo Pharma is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.

The drug maker reported 90.58% jump in consolidated net profit to Rs 936.29 crore on 13.82% rise in revenue from operations to Rs 7,271.23 crore in Q3 FY24 over Q3 FY23.

The scrip shed 0.19% to end at Rs 1,121 on the BSE.

ATTENTION INVESTORS : Prevent unauthorised transactions in your account Update your mobile numbers / email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile / email at the end of the day .... Issued in the interest of Investors.    ||     Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.   ||    KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
Attention Investors

1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020

2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on
your email id and/or mobile number to create pledge.

3. Pay 20% upfront margin of the transaction value to trade in cash market segment.

4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191
dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.

(Issued in the interest of Investors.)

Important Message

This is to inform that, many instances were reported by general public where fraudsters are cheating general public by misusing our brand name RUDRA SHARES.
The fraudsters are luring the general public to transfer them money by falsely committing attractive brokerage / investment schemes of share market and/or Mutual Funds
and/or personal loan facilities. Though as for as possible, we initiate legal actions against the fraudsters, we request you to not fall prey to such fraudsters. You can check
about our products and services by visiting our website www.rudrashares.com. You can also write to us at compliance@rudrashares.com, to know more about products and services.

SEBI REGN. (STOCK BROKER) - NSE-CM/FO/CD / BSE-CM/FO/CD / MCX / NCDEX - INZ000004937
SEBI REGN. (DP)IN-DP-558-2021
@ 2015. ALL RIGHTS RESERVED. RUDRA SHARES & STOCK BROKERS LTD.
Designed, developed and powered by C-MOTS Infotech (ISO 9001:2015 certified)